Citadel Advisors’s PepGen PEPG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$368K Sell
207,922
-59,867
-22% -$336K ﹤0.01% 10001
2025
Q4
$1.74M Sell
267,789
-29,469
-10% -$153K ﹤0.01% 6207
2025
Q3
$1.37M Buy
+297,258
New +$479K ﹤0.01% 6849
2025
Q2
Sell
-91
Closed -$128 14434
2025
Q1
$128 Sell
91
-26
-22% -$54 ﹤0.01% 14326
2024
Q4
$443 Buy
+117
New +$729 ﹤0.01% 14324
2022
Q4
Sell
-343,751
Closed -$3.12M 15298
2022
Q3
$3.12M Buy
343,751
+50,210
+17% +$494K ﹤0.01% 4740
2022
Q2
$2.92M Buy
+293,541
New +$3.27M ﹤0.01% 4805

Other funds holding PEPG

Citadel Advisors's PEPG Position: Q1 2026 in Review

Citadel Advisors reduced its PepGen (PEPG) stake by 22% in Q1 2026, selling an estimated $336K and leaving 207,922 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #10001.

Citadel Advisors first reported a position in PEPG in Q2 2022 and has held it in 7 quarters since. The position peaked at $3.12M in Q3 2022. 93 funds tracked by Wall St. Rank hold PEPG as of Q1 2026.

  • Citadel Advisors held 207,922 shares of PepGen worth $368K as of Q1 2026.
  • Citadel Advisors sold 59,867 PepGen shares in Q1 2026, an estimated $336K.
  • PepGen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10001 holding.
  • Citadel Advisors first reported a position in PepGen in Q2 2022 and has held it in 7 quarters since.
  • Citadel Advisors's PepGen position peaked at $3.12M in Q3 2022.
  • 93 funds tracked by Wall St. Rank held PepGen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.